TABLE 3.

Prognostic Factors Associated With 5-year Relapse-free Survival

		5-year RFS (%)
Patient Cohort	Patients, n (%)	%	SE	Breslow	P
Sex
Male	11 (42.3)	40.0	15.5	5.14	0.02*
Female	15 (57.7)	64.2	17.6
Age (y)
0-2	15 (57.7)	60.1	14.2	0.05	0.82
>2	11 (42.3)	50.6	18.7
Stage
II	3 (11.5)
III	11 (42.3)	50.9	16.3	0.71	0.40
IV	12 (46.2)	62.5	17.1
AFP (ng/mL)
≤60,000	12 (46.2)	56.3	18.8	0.01	0.91
>60,000	14 (53.8)	50.9	15.8
Initial tumor size
≤3 cm×4 cm	10 (38.5)	62.2	17.8	1.28	0.26
>3 cm×4 cm	16 (61.5)	51.6	14.7
Pathologic response
No malignant residues	9 (45.0)	100.0	0	4.63	0.03*
Malignant residues	11 (55.0)	46.7	16.6

AFP indicates alpha-fetoprotein; RFS, relapse-free survival.

^*P<0.05.